SAFETY DATA SHEET
LymphoTrack® Assays - MiSeqTM

Catalog Number

Description

71210009

LymphoTrack IGH FR1 Assay Kit A - MiSeq

71210039

LymphoTrack IGH FR1 Assay Panel - MiSeq

71210059

LymphoTrack IGHV Leader Somatic Hypermutation Assay Kit A - MiSeq

71210069

LymphoTrack IGHV Leader Somatic Hypermutation Assay Panel - MiSeq

71210089

LymphoTrack IGH FR2 Assay Kit A - MiSeq

71210099

LymphoTrack IGH FR2 Assay Panel - MiSeq

71210109

LymphoTrack IGH FR3 Assay Kit A - MiSeq

71210119

LymphoTrack IGH FR3 Assay Panel - MiSeq

71210129

LymphoTrack IGH FR1/2/3 Assay Kit A - MiSeq

71210139

LymphoTrack IGH FR1/2/3 Assay Panel - MiSeq

71210149

LymphoTrack IGH FR1 Assay Panel B – MiSeq

71220009

LymphoTrack IGK Assay Kit A - MiSeq

71220019

LymphoTrack IGK Assay Panel - MiSeq

72250009

LymphoTrack TRB Assay Kit A - MiSeq

72250019

LymphoTrack TRB Assay Panel - MiSeq

72270009

LymphoTrack TRG Assay Panel - MiSeq

72270019

LymphoTrack TRG Assay Kit A - MiSeq

SDS – LymphoTrack Assays - MiSeq (CLP)-EN Rev. A | November 2023

1 / 24

SAFETY DATA SHEETThis safety data sheet was created pursuant to the requirements of:Regulation (EC) No. 1907/2006 as amended by Commission Regulation (EU)2020/878 and Regulation (EC) No. 1272/2008
Issuing Date 27-Apr-2023

Revision Date 27-Apr-2023

Revision Number 1

SECTION 1: Identification of the substance/mixture and of the company/undertaking
1.1.

Product identifier
Product Code(s)Product Name

Synonyms

40880008

IGH SHM Positive Control DNA

None

40880009

IGH Positive Control

None40880018

IGK PositiveNone40880058

TRB Positive Control

None40920018

NGS Negative Control

None42270019

TRG POS (+) Control

None

Pure substance/mixture

Mixture1.2.

Relevant identified uses of the substance or mixture and uses advised against
Recommended use
Assay reagent
Uses advised against
For professional use only

1.3.

Details of the supplier of the safety data sheet
Importer
Invivoscribe Technologies
Zeppelinstrasse 185399 Hallbergmoos
Germany
Phone: +49 89 904 299 800

Supplier
Invivoscribe, Inc.
10222 Barnes Canyon Rd
Bldg. 1San Diego, CA 92121
Phone: +1 858-224-6600

Distributor
Invivoscribe Technologies, SARL
c/o Ficorec Domiciliation Services
132, Boulevard Michelet
Hall Nord – 5ème étage
13008 Marseille
FRANCE
Tel: +33 (0)4 42 01 78 10

For further information, please contact
E-mail address
customerservice@invivoscribe.com
1.4.

Emergency telephone number
Emergency telephone+49 89 904 299 800 (M-F 8:00 – 16:30 CET)Emergency telephone - §45 - (EC)1272/2008
Europe112

SECTION 2: Hazards identification
2.1.

Classification of the substance or mixture
Classification according to Regulation (EC) No. 1272/2008 [CLP]This substance is classified as not hazardous according to regulation (EC) 1272/2008 [CLP].

2.2.

Label elements
Hazard statements

2.3.

Not classified.
Unknown aquatic toxicity

Contains 0 % of components with unknown hazards to the aquatic environment.

Other hazards
No information available.
Endocrine Disruptor Information

This product does not contain any known or suspected endocrine disruptors.

SDS – LymphoTrack Assays - MiSeq (CLP)-EN Rev. A | November 2023

2 / 24

LymphoTrack® Assays - MiSeqTM

SECTION 3: Composition/information on ingredients
3.1

Substances
The product contains no substances which at their given concentration, are considered to be hazardous to health.
Full text of H- and EUH-phrases: see section 16
Acute Toxicity Estimate
If LD50/LC50 data is not available or does not correspond to the classification category, then the appropriate conversion value
from CLP Annex I, Table 3.1.2, is used to calculate the acute toxicity estimate (ATEmix) for classifying a mixture based on its
components
This product does not contain candidate substances of very high concern at a concentration >=0.1% (Regulation (EC) No. 1907/2006(REACH), Article 59)

SECTION 4: First aid measures
4.1.

Description of first aid measures
Inhalation
Eye contact
Skin contact
Ingestion

Remove to fresh air. Get medical attention if symptoms occur.
Rinse thoroughly with plenty of water for at least 15 minutes, lifting lower and upper eyelids.
Consult a physician.
Wash skin with soap and water. Get medical attention if symptoms occur.
Do NOT induce vomiting. Never give anything by mouth to an unconscious person. Rinse mouth.
Get medical attention if symptoms occur.

4.2.

Most important symptoms and effects, both acute and delayed
Symptoms
None known.
Effects of Exposure
No information available.

4.3.

Indication of any immediate medical attention and special treatment needed
Note to physicians
Treat symptomatically.

SECTION 5: Firefighting measures
5.1.

Extinguishing media
Suitable Extinguishing MediaUse extinguishing measures that are appropriate to local circumstances and thesurrounding environment.
No information available.

Unsuitable extinguishing media
5.2.

Special hazards arising from the substance or mixture
Specific hazards arising from the chemical
No information available.

5.3.

Advice for firefighters
Special protective equipment andprecautions for fire-fighters

Firefighters should wear self-contained breathing apparatus and full firefighting
turnout gear. Use personal protection equipment.

SECTION 6: Accidental release measures
6.1.

Personal precautions, protective equipment and emergency procedures
Personal precautions
Ensure adequate ventilation.
For emergency responders
Use personal protection recommended in Section 8.

6.2.

Environmental precautions
Environmental precautions

6.3.

See Section 12 for additional Ecological Information.

Methods and material for containment and cleaning up

SDS – LymphoTrack Assays - MiSeq (CLP)-EN Rev. A | November 2023

3 / 24

LymphoTrack® Assays - MiSeqTM

SECTION 6: Accidental release measures
Methods for containment
Methods for cleaning up

Prevent further leakage or spillage if safe to do so.
Dam up. Soak up with inert absorbent material. Take up mechanically, placing in appropriate
containers for disposal.
Clean contaminated objects and areas thoroughly observing environmental regulations.

Prevention of secondary hazards
6.4.

Reference to other sections
Reference to other sections

See section 8 for more information See section 13 for more information

SECTION 7: Handling and storage
7.1.

Precautions for safe handling
Advice on safe handling
General hygiene
considerations

Handle in accordance with good industrial hygiene and safety practice.
Handle in accordance with good industrial hygiene and safety practice.

7.2.

Conditions for safe storage, including any incompatibilities
Storage Conditions
Keep containers tightly closed in a dry, cool and well-ventilated place.
Storage class (TRGS 510)
Storage class 10.

7.3.

Specific end use(s)Specific use(s)The identified uses for this product are detailed in Section 1.2.

SECTION 8: Exposure controls/personal protection
8.1.

Control parameters
Exposure Limits

This product, as supplied, does not contain any hazardous materials with occupational exposure
limits established by the region specific regulatory bodies.

Biological occupational exposure limits
This product, as supplied, does not contain any hazardous materials with biological limits established by the region-specificregulatory bodies.
Derived No Effect Level (DNEL) - Workers
No information available.
Derived No Effect Level (DNEL) - General Public
No information available.
Predicted No Effect Concentration (PNEC)
No information available.
8.2.

Exposure controls
Engineering controls

Personal protective equipment
Eye/face protection
Hand protection
Skin and body protection
Respiratory protection
General hygiene considerations
Environmental exposure controls

Showers
Eyewash stations
Ventilation systems.

Wear safety glasses with side shields (or goggles). Eye protection must conform to standard
EN 166.
Wear suitable gloves. Gloves must conform to standard EN 374.
Wear suitable protective clothing. (EN ISO 6529).
No protective equipment is needed under normal use conditions. If exposure limits are
exceeded or irritation is experienced, ventilation and evacuation may be required.
Handle in accordance with good industrial hygiene and safety practice.
No information available.

SECTION 9: Physical and chemical properties
9.1.

Information on basic physical and chemical properties

SDS – LymphoTrack Assays - MiSeq (CLP)-EN Rev. A | November 2023

4 / 24

LymphoTrack® Assays - MiSeqTM

SECTION 9: Physical and chemical properties
Appearance
Physical state
Color
Odor
Odor threshold

LiquidColorlessOdorless
No information available

Property
Melting point / freezing point
Initial boiling point and boiling range
Flammability
Flammability Limit in Air
Upper flammability or explosive limits
Lower flammability or explosive limits
Flash point
Autoignition temperature
Decomposition temperaturepH
pH (as aqueous solution)
Kinematic viscosity
Dynamic viscosity
Water solubility
Solubility(ies)
Partition coefficient
Vapor pressure
Relative density
Bulk density
Liquid density
Relative vapor density
Particle characteristics
Particle size
Particle size distribution
9.2.

ValuesRemarks • Method
No data available
No data available
No data available
No data available
No data available
No data available
No data available
No data available
No data available
No data available
No data available
No data available
No data available
No data available
No data available
No data available
No data available
No data available
No data available
No data available
No data available
No data available
No data available
No data available

Other information
9.2.1.
9.2.2.

Information with regard to physical hazard classes
Not applicable
Other safety characteristics
No information available

SECTION 10: Stability and reactivity
10.1. Reactivity
Reactivity
10.2. Chemical stability
Stability
Explosion data

None under normal use conditions.

Stable under normal conditions.

Sensitivity to mechanical impact

None.

Sensitivity to static discharge

None.

10.3. Possibility of hazardous reactions
Possibility of hazardous reactions

None under normal processing.

SDS – LymphoTrack Assays - MiSeq (CLP)-EN Rev. A | November 2023

5 / 24

LymphoTrack® Assays - MiSeqTM

SECTION 10: Stability and reactivity
10.4. Conditions to avoid
Conditions to avoid

None known based on information supplied.

10.5. Incompatible materials
Incompatible materials

None known based on information supplied.

10.6. Hazardous decomposition products
Hazardous decomposition products

None known based on information supplied.

SECTION 11: Toxicological information
11.1. Information on hazard classes as defined in Regulation (EC) No 1272/2008
Information on likely routes of exposure
Product Information
Inhalation
Specific test data for the substance or mixture is not available.
Eye contact

Specific test data for the substance or mixture is not available. Contact with eyes may cause irritation.

Skin contact

Specific test data for the substance or mixture is not available.

Ingestion

Specific test data for the substance or mixture is not available.

Symptoms related to the physical, chemical and toxicological characteristics
Symptoms
None known.
Acute toxicity
Numerical measures of toxicity
Based on available data, the classification criteria are not met.
Component Information
Delayed and immediate effects as well as chronic effects from short and long-term exposure
Skin corrosion/irritation
Based on available data, the classification criteria are not met.
Serious eye damage/eye irritation
Based on available data, the classification criteria are not met.
Respiratory or skin sensitization
Based on available data, the classification criteria are not met.
Germ cell mutagenicity
Based on available data, the classification criteria are not met.
Carcinogenicity
Based on available data, the classification criteria are not met.
Reproductive toxicity
Based on available data, the classification criteria are not met.
STOT - single exposure
Based on available data, the classification criteria are not met.
STOT - repeated exposure
Based on available data, the classification criteria are not met.
Aspiration hazard
Based on available data, the classification criteria are not met.
11.2. Information on other hazards
11.2.1.
Endocrine disrupting properties
Endocrine disrupting properties
11.2.2.
Other information
Other adverse effects

This product does not contain any known or suspected endocrine disruptors.
No information available.

SECTION 12: Ecological information
12.1. Toxicity
Ecotoxicity
Unknown aquatic toxicity

Based on available data, the classification criteria are not met. Based on available data, theclassification criteria are not met.
Contains 0 % of components with unknown hazards to the aquatic environment.

12.2. Persistence and degradability

SDS – LymphoTrack Assays - MiSeq (CLP)-EN Rev. A | November 2023

6 / 24

LymphoTrack® Assays - MiSeqTM

SECTION 12: Ecological information
Persistence and degradability

No information available.

12.3. Bioaccumulative potential
Bioaccumulation

No information available.

12.4. Mobility in soil
Mobility in soil

No information available.

12.5. Results of PBT and vPvB assessment
PBT and vPvB assessment
The product does not contain any substance(s) classified as PBT or vPvB.
12.6. Endocrine disrupting properties
Endocrine disrupting
properties
12.7. Other adverse effects
Other adverse effects

This product does not contain any known or suspected endocrine disruptors.

No information available.

SECTION 13: Disposal considerations
13.1. Waste treatment methods
Waste from residues/unused
products
Contaminated packaging
Waste codes / waste
designations according to EWC/ AVV

Dispose of in accordance with local regulations. Dispose of waste in accordance withenvironmental legislation.
Do not reuse empty containers.
According to the European Waste Catalog, Waste Codes are not product specific, but application
specific. Waste codes should be assigned by the user based on the application for which the
product was used.

SECTION 14: Transport information
IMDG
14.1
14.2
14.3
14.4
14.5
14.6

Not regulated
UN number or ID number
UN proper shipping name
Transport hazard class(es)Packing group
Environmental hazards
Special Precautions for Users
Special Provisions

Not regulated
Not regulated
Not regulated
Not applicableNot applicable

14.7

Maritime transport in bulk according
to IMO instruments

No information available

14.1
14.2
14.3
14.4
14.5
14.6

UN numberUN proper shipping name
Transport hazard class(es)Packing group
Environmental hazards
Special Precautions for Users
Special Provisions

RID

ADR
14.1
14.2

UN number or ID number
UN proper shipping nameNone

Not regulated
Not regulated
Not regulated
Not regulated
Not applicableNot applicableNone
Not regulated
Not regulated
Not regulated

SDS – LymphoTrack Assays - MiSeq (CLP)-EN Rev. A | November 2023

7 / 24

LymphoTrack® Assays - MiSeqTM

SECTION 14: Transport information
14.3
14.4
14.5
14.6

Transport hazard class(es)Packing group
Environmental hazards
Special Precautions for Users
Special Provisions

Not regulated
Not applicableNot applicable
None

IATA
14.1
14.2
14.3
14.4
14.5
14.6

Not regulated
Not regulated
Not regulated
Not regulated
Not applicableNot applicable

UN number or ID number
UN proper shipping name
Transport hazard class(es)Packing group
Environmental hazards
Special Precautions for Users
Special Provisions

None

Note:

None

SECTION 15: Regulatory information
15.1. Safety, health and environmental regulations/legislation specific for the substance or mixture
National regulations
Germany
Water hazard class (WGK)
non-hazardous to water (nwg)
European Union
Take note of Directive 98/24/EC on the protection of the health and safety of workers from the risks related to chemical agents at
work.
Authorizations and/or restrictions on use:
This product does not contain substances subject to authorization (Regulation (EC) No. 1907/2006 (REACH), Annex XIV) This productdoes not contain substances subject to restriction (Regulation (EC) No. 1907/2006 (REACH), Annex XVII)Persistent Organic Pollutants
Not applicable
Ozone-depleting substances (ODS) regulation (EC) 1005/2009
Not applicable
International Inventories
Contact supplier for inventory compliance status
15.2. Chemical safety assessment
Chemical Safety Report

No information available

SECTION 16: Other information
Key or legend to abbreviations and acronyms used in the safety data sheet
Legend
ATE: Acute Toxicity Estimate
SVHC: Substances of Very High Concern for Authorization:
PBT: Persistent, Bioaccumulative, and Toxic (PBT) Substances
vPvB: Very Persistent and very Bioaccumulative (vPvB) Substances
Legend Section 8: Exposure controls/personal protection
TWA
TWA (time-weighted average)
Ceiling
Maximum limit value
SDS – LymphoTrack Assays - MiSeq (CLP)-EN Rev. A | November 2023

STEL*

STEL (Short Term Exposure Limit)
Skin designation
8 / 24

LymphoTrack® Assays - MiSeqTM

SECTION 16: Other information
SCBA

Self-contained breathing apparatus

Classification procedure
Classification according to Regulation (EC) No. 1272/2008 [CLP]
Acute oral toxicity
Acute dermal toxicity
Acute inhalation toxicity - gas
Acute inhalation toxicity - vapor
Acute inhalation toxicity - dust/mist
Skin corrosion/irritation
Serious eye damage/eye irritation
Respiratory sensitization
Skin sensitization
Mutagenicity
Carcinogenicity
Reproductive toxicity
STOT - single exposure
STOT - repeated exposure
Acute aquatic toxicity
Chronic aquatic toxicity
Aspiration hazard
Ozone

Method Used
Calculation method
Calculation method
Calculation method
Calculation method
Calculation method
Calculation method
Calculation method
Calculation method
Calculation method
Calculation method
On basis of test data
Calculation method
Calculation method
Calculation method
Calculation method
Calculation method
Calculation method
Calculation method

Key literature references and sources for data used to compile the SDS
Agency for Toxic Substances and Disease Registry (ATSDR)
U.S. Environmental Protection Agency ChemView Database
European Food Safety Authority (EFSA)
European Chemicals Agency (ECHA) Committee for Risk Assessment (ECHA_RAC)
European Chemicals Agency (ECHA) (ECHA_API)
EPA (Environmental Protection Agency)
Acute Exposure Guideline Level(s) (AEGL(s))
U.S. Environmental Protection Agency Federal Insecticide, Fungicide, and Rodenticide Act
U.S. Environmental Protection Agency High Production Volume Chemicals
Food Research Journal
Hazardous Substance Database
International Uniform Chemical Information Database (IUCLID)
Japan GHS Classification
Australia National Industrial Chemicals Notification and Assessment Scheme (NICNAS)
NIOSH (National Institute for Occupational Safety and Health)National Library of Medicine's ChemID Plus (NLM CIP)
National Library of Medicine’s PubMed database (NLM PUBMED)
United States of America National Toxicology Program (NTP)New Zealand's Chemical Classification and Information Database (CCID)
Organization for Economic Co-operation and Development Environment, Health, and Safety Publications
Organization for Economic Co-operation and Development High Production Volume Chemicals Program
Organization for Economic Co-operation and Development Screening Information Data Set
World Health Organization
Issuing Date
Revision Date

27-Apr-2023
27-Apr-2023

SDS – LymphoTrack Assays - MiSeq (CLP)-EN Rev. A | November 2023

9 / 24

LymphoTrack® Assays - MiSeqTM

SECTION 16: Other information
Revision Note

Initial Release.

This safety data sheet complies with the requirements of Commission Regulation (EU) 2020/878 of 18 June 2020 amending Regulation(EC) No. 1907/2006
Disclaimer
The information provided in this Safety Data Sheet is correct to the best of our knowledge, information and belief at the date of its
publication. The information given is designed only as a guidance for safe handling, use, processing, storage, transportation, disposal
and release and is not to be considered a warranty or quality specification. The information relates only to the specific material
designated and may not be valid for such material used in combination with any other materials or in any process, unless specified in
the text.

SDS – LymphoTrack Assays - MiSeq (CLP)-EN Rev. A | November 2023

10 / 24

SAFETY DATA SHEETThis safety data sheet was created pursuant to the requirements of:Regulation (EC) No. 1907/2006 as amended by Commission Regulation (EU)2020/878 and Regulation (EC) No. 1272/2008
Issuing Date 27-Apr-2023

Revision Date 27-Apr-2023

Revision Number 1

SECTION 1: Identification of the substance/mixture and of the company/undertaking
1.1.

Product identifier
Product Code(s)21210009
21210019
21210029
21210039
21210049
21210059
21210069
21210079
21210089
21210099
21210109
212101192121012921210139
21210149
21210159
21210169
21210179
21210189
21210199
21210209
21210219
21210229
21210239
21210249
21210259
21210269
21210279
21210289
21210299
21210309
21210319
21210329
21210339
21210349
21210359
21210369
21210379
21210389
21210399
21210409

Product Name
IGH FR1 MiSeq 01
IGH FR1 MiSeq 02
IGH FR1 MiSeq 03
IGH FR1 MiSeq 04
IGH FR1 MiSeq 05
IGH FR1 MiSeq 06
IGH FR1 MiSeq 07
IGH FR1 MiSeq 08
IGH FR1 MiSeq 09
IGH FR1 MiSeq 10
IGH FR1 MiSeq 11
IGH FR1 MiSeq 12
IGH FR1 MiSeq 13
IGH FR1 MiSeq 14
IGH FR1 MiSeq 15
IGH FR1 MiSeq 16
IGH FR1 MiSeq 18
IGH FR1 MiSeq 19
IGH FR1 MiSeq 20
IGH FR1 MiSeq 21
IGH FR1 MiSeq 22
IGH FR1 MiSeq 23
IGH FR1 MiSeq 25
IGH FR1 MiSeq 27
IGH Leader MiSeq 01
IGH Leader MiSeq 02
IGH Leader MiSeq 03
IGH Leader MiSeq 04
IGH Leader MiSeq 05
IGH Leader MiSeq 06
IGH Leader MiSeq 07
IGH Leader MiSeq 08
IGH Leader MiSeq 09
IGH Leader MiSeq 10
IGH Leader MiSeq 11
IGH Leader MiSeq 12
IGH Leader MiSeq 13
IGH Leader MiSeq 14
IGH Leader MiSeq 15
IGH Leader MiSeq 16
IGH Leader MiSeq 18

SDS – LymphoTrack Assays - MiSeq (CLP)-EN Rev. A | November 2023

Synonyms
None
None
None
None
None
None
None
None
None
None
None
None
None
None
None
None
None
None
None
None
None
None
None
None
None
None
None
None
None
None
None
None
None
None
None
None
None
None
None
None
None

11 / 24

LymphoTrack® Assays - MiSeqTM

SECTION 1: Identification of the substance/mixture and of the company/undertaking
Product Code(s)21210419
21210429
21210439
21210449
21210459
21210469
21210479
21210489
21210499
21210509
21210519
21210529
21210539
21210549
21210559
21210569
21210579
21210589
21210599
21210609
21210619
21210629
21210639
21210649
21210659
21210669
21210679
21210689
21210699
21210709
21210719
21210729
21210739
21210749
21210759
21210769
21210779
21210789
21210799
21210809
21210819
21210829
21210839
21210849
21210859
21210869
21210879
21210889

Product Name
IGH Leader MiSeq 19
IGH Leader MiSeq 20
IGH Leader MiSeq 21
IGH Leader MiSeq 22
IGH Leader MiSeq 23
IGH Leader MiSeq 25
IGH Leader MiSeq 27
IGH FR2 MiSeq 01
IGH FR2 MiSeq 02
IGH FR2 MiSeq 03
IGH FR2 MiSeq 04
IGH FR2 MiSeq 05
IGH FR2 MiSeq 06
IGH FR2 MiSeq 07
IGH FR2 MiSeq 08
IGH FR2 MiSeq 09
IGH FR2 MiSeq 10
IGH FR2 MiSeq 11
IGH FR2 MiSeq 12
IGH FR2 MiSeq 13
IGH FR2 MiSeq 14
IGH FR2 MiSeq 15
IGH FR2 MiSeq 16
IGH FR2 MiSeq 18
IGH FR2 MiSeq 19
IGH FR2 MiSeq 20
IGH FR2 MiSeq 21
IGH FR2 MiSeq 22
IGH FR2 MiSeq 23
IGH FR2 MiSeq 25
IGH FR2 MiSeq 27
IGH FR3 MiSeq 01
IGH FR3 MiSeq 02
IGH FR3 MiSeq 03
IGH FR3 MiSeq 04
IGH FR3 MiSeq 05
IGH FR3 MiSeq 06
IGH FR3 MiSeq 07
IGH FR3 MiSeq 08
IGH FR3 MiSeq 09
IGH FR3 MiSeq 10
IGH FR3 MiSeq 11
IGH FR3 MiSeq 12
IGH FR3 MiSeq 13
IGH FR3 MiSeq 14
IGH FR3 MiSeq 15
IGH FR3 MiSeq 16
IGH FR3 MiSeq 18

SDS – LymphoTrack Assays - MiSeq (CLP)-EN Rev. A | November 2023

Synonyms
None
None
None
None
None
None
None
None
None
None
None
None
None
None
None
None
None
None
None
None
None
None
None
None
None
None
None
None
None
None
None
None
None
None
None
None
None
None
None
None
None
None
None
None
None
None
None
None
12 / 24

LymphoTrack® Assays - MiSeqTM

SECTION 1: Identification of the substance/mixture and of the company/undertaking
Product Code(s)21210899
21210909
21210919
21210929
21210939
21210949
21210959
21210969
21210979
21210989
21210999
21211009
21211019
21211029
21211039
21211049
21211059
21211069
21211079
21211089
21211099
21211109
2121111921211129
21211139
21211149
21211159
21211169
21211179
21211189
21211199
21220009
21220019
21220029
21220039
21220049
21220059
21220069
21220079
21220089
21220099
21220109212201192122012921220139
21220149
21220159
21220169

Product Name
IGH FR3 MiSeq 19
IGH FR3 MiSeq 20
IGH FR3 MiSeq 21
IGH FR3 MiSeq 22
IGH FR3 MiSeq 23
IGH FR3 MiSeq 25
IGH FR3 MiSeq 27
IGH FR1 MiSeq 17
IGH FR1 MiSeq 24
IGH FR1 MiSeq 26
IGH FR1 MiSeq 28
IGH FR1 MiSeq 29
IGH FR1 MiSeq 30
IGH FR1 MiSeq 31
IGH FR1 MiSeq 32
IGH FR1 MiSeq 33
IGH FR1 MiSeq 34
IGH FR1 MiSeq 35
IGH FR1 MiSeq 36
IGH FR1 MiSeq 37
IGH FR1 MiSeq 38
IGH FR1 MiSeq 39
IGH FR1 MiSeq 40
IGH FR1 MiSeq 41
IGH FR1 MiSeq 42
IGH FR1 MiSeq 43
IGH FR1 MiSeq 44
IGH FR1 MiSeq 45
IGH FR1 MiSeq 46
IGH FR1 MiSeq 47
IGH FR1 MiSeq 48
IGK MiSeq 01
IGK MiSeq 02
IGK MiSeq 03
IGK MiSeq 04
IGK MiSeq 05
IGK MiSeq 06
IGK MiSeq 07
IGK MiSeq 08
IGK MiSeq 09
IGK MiSeq 10
IGK MiSeq 11
IGK MiSeq 12
IGK MiSeq 13
IGK MiSeq 14
IGK MiSeq 15
IGK MiSeq 16
IGK MiSeq 18

SDS – LymphoTrack Assays - MiSeq (CLP)-EN Rev. A | November 2023

Synonyms
None
None
None
None
None
None
None
None
None
None
None
None
None
None
None
None
None
None
None
None
None
None
None
None
None
None
None
None
None
None
None
None
None
None
None
None
None
None
None
None
None
None
None
None
None
None
None
None
13 / 24

LymphoTrack® Assays - MiSeqTM

SECTION 1: Identification of the substance/mixture and of the company/undertaking
Product Code(s)21220179
21220189
21220199
21220209
21220219
21220229
21220239
22250009
22250019
22250029
22250039
22250049
22250059
22250069
22250079
22250089
22250099
22250109
222501192225012922250139
22250149
22250159
22250169
22250179
22250189
22250199
22250209
22250219
22250229
22250239
22270019
22270029
22270039
22270049
22270059
22270069
22270079
22270089
22270099
22270109
222701192227012922270139
22270149
22270159
22270169
22270189

Product Name
IGK MiSeq 19
IGK MiSeq 20
IGK MiSeq 21
IGK MiSeq 22
IGK MiSeq 23
IGK MiSeq 25
IGK MiSeq 27
TRB MiSeq 01
TRB MiSeq 02
TRB MiSeq 03
TRB MiSeq 04
TRB MiSeq 05
TRB MiSeq 06
TRB MiSeq 07
TRB MiSeq 08
TRB MiSeq 09
TRB MiSeq 10
TRB MiSeq 11
TRB MiSeq 12
TRB MiSeq 13
TRB MiSeq 14
TRB MiSeq 15
TRB MiSeq 16
TRB MiSeq 18
TRB MiSeq 19
TRB MiSeq 20
TRB MiSeq 21
TRB MiSeq 22
TRB MiSeq 23
TRB MiSeq 25
TRB MiSeq 27
TRG MiSeq 01
TRG MiSeq 02
TRG MiSeq 03
TRG MiSeq 04
TRG MiSeq 05
TRG MiSeq 06
TRG MiSeq 07
TRG MiSeq 08
TRG MiSeq 09
TRG MiSeq 10
TRG MiSeq 11
TRG MiSeq 12
TRG MiSeq 13
TRG MiSeq 14
TRG MiSeq 15
TRG MiSeq 16
TRG MiSeq 18

SDS – LymphoTrack Assays - MiSeq (CLP)-EN Rev. A | November 2023

Synonyms
None
None
None
None
None
None
None
None
None
None
None
None
None
None
None
None
None
None
None
None
None
None
None
None
None
None
None
None
None
None
None
None
None
None
None
None
None
None
None
None
None
None
None
None
None
None
None
None
14 / 24

LymphoTrack® Assays - MiSeqTM

SECTION 1: Identification of the substance/mixture and of the company/undertaking
Product Code(s)22270199
22270209
22270219
22270229
22270239
22270259
22270279

Product Name
TRG MiSeq 19
TRG MiSeq 20
TRG MiSeq 21
TRG MiSeq 22
TRG MiSeq 23
TRG MiSeq 25
TRG MiSeq 27

Pure substance/mixture

Mixture1.2.

Relevant identified uses of the substance or mixture and uses advised against
Recommended use
Assay reagent
Uses advised against
For professional use only

1.3.

Details of the supplier of the safety data sheet
Importer
Invivoscribe Technologies
Zeppelinstrasse 185399 Hallbergmoos
Germany
Phone: +49 89 904 299 800

For further information, please contact
E-mail address
1.4.

Synonyms
None
None
None
None
None
None
None

Supplier
Invivoscribe, Inc.
10222 Barnes Canyon Rd
Bldg. 1San Diego, CA 92121
Phone: +1 858-224-6600

Distributor
Invivoscribe Technologies, SARL
c/o Ficorec Domiciliation Services
132, Boulevard Michelet
Hall Nord – 5ème étage
13008 Marseille
FRANCE
Tel: +33 (0)4 42 01 78 10

customerservice@invivoscribe.com

Emergency telephone number
Emergency telephone+49 89 904 299 800 (M-F 8:00 – 16:30 CET)Emergency telephone - §45 - (EC)1272/2008
Europe112

SECTION 2: Hazards identification
2.1.

Classification of the substance or mixture
Classification according to Regulation (EC) No. 1272/2008 [CLP]This mixture is classified as not hazardous according to regulation (EC) 1272/2008 [CLP]

2.2.

Label elements
Hazard statements

2.3.

Not classified.
Unknown aquatic toxicity

Contains 0 % of components with unknown hazards to the aquatic environment.

Other hazards
Endocrine Disruptor Information

This product does not contain any known or suspected endocrine disruptors.

SECTION 3: Composition/information on ingredients
3.1

Substances
Not applicable

3.2

Mixtures

SDS – LymphoTrack Assays - MiSeq (CLP)-EN Rev. A | November 2023

15 / 24

LymphoTrack® Assays - MiSeqTM

SECTION 3: Composition/information on ingredients
Chemical name

Weight%REACH
registration
numberEC No (EU
Index No)Classificationaccording toRegulation (EC) No.
1272/2008 [CLP][C]

Specific
concentration
limit (SCL)

MFactorDimethyl sulfoxide
1-5
No data
200-664-3
67-68-5
available
Classification according to Regulation (EC) No. 1272/2008 [CLP] - Notes[C] - Components with occupational exposure limits and/or biological occupational exposure limits requiring monitoring

M-Factor(long-term)-

Full text of H- and EUH-phrases: see section 16
Acute Toxicity Estimate
If LD50/LC50 data is not available or does not correspond to the classification category, then the appropriate conversion value from
CLP Annex I, Table 3.1.2, is used to calculate the acute toxicity estimate (ATEmix) for classifying a mixture based on its components
Chemical name
Oral LD50 mg/kg
Dermal LD50
Inhalation LC50 - 4
Inhalation LC50 - 4
Inhalation LC50 - 4
mg/kg
hour - dust/mist hour - vapor - mg/Lhour - gas - ppm
mg/L
Dimethyl sulfoxide
28300
40000
5.3353No data available
No data available
67-68-5This product does not contain candidate substances of very high concern at a concentration >=0.1% (Regulation (EC) No. 1907/2006(REACH), Article 59)

SECTION 4: First aid measures
4.1.

Description of first aid measures
Inhalation
Remove to fresh air. Get medical attention if symptoms occur.
Eye contact
Rinse thoroughly with plenty of water, also under the eyelids. Get medical attention if symptoms occur.
Skin contact
Wash skin with soap and water. Get medical attention if symptoms occur.
Ingestion
Do NOT induce vomiting. Never give anything by mouth to an unconscious person. Rinse mouth. Get medical
attention if symptoms occur.

4.2.

Most important symptoms and effects, both acute and delayed
Symptoms
None known.
Effects of Exposure
No information available.

4.3.

Indication of any immediate medical attention and special treatment needed
Note to physicians
Treat symptomatically.

SECTION 5: Firefighting measures
5.1.

Extinguishing media
Suitable Extinguishing Media
Unsuitable extinguishing media

Use extinguishing measures that are appropriate to local circumstances and thesurrounding environment.
No information available.

5.2.

Special hazards arising from the substance or mixture
Specific hazards arising from the chemical
No information available.

5.3.

Advice for firefighters
Special protective equipment and precautions
for fire-fighters

Firefighters should wear self-contained breathing apparatus and full firefighting
turnout gear. Use personal protection equipment.

SECTION 6: Accidental release measures
6.1.

Personal precautions, protective equipment and emergency procedures

SDS – LymphoTrack Assays - MiSeq (CLP)-EN Rev. A | November 2023

16 / 24

LymphoTrack® Assays - MiSeqTM

SECTION 6: Accidental release measures

6.2.

Personal precautions
For emergency responders

Ensure adequate ventilation.
Use personal protection recommended in Section 8.

Environmental precautions
Environmental precautions

See Section 12 for additional Ecological Information.

6.3.

Methods and material for containment and cleaning up
Methods for containment
Prevent further leakage or spillage if safe to do so.
Methods for cleaning up
Dam up. Soak up with inert absorbent material. Take up mechanically, placing in appropriate
containers for disposal.
Prevention of secondary hazards
Clean contaminated objects and areas thoroughly observing environmental regulations.

6.4.

Reference to other sections
Reference to other sections

See section 8 for more information See section 13 for more information

SECTION 7: Handling and storage
7.1.

Precautions for safe handling
Advice on safe handling
General hygiene considerations

Handle in accordance with good industrial hygiene and safety practice.
Handle in accordance with good industrial hygiene and safety practice.

7.2.

Conditions for safe storage, including any incompatibilities
Storage Conditions
Keep containers tightly closed in a dry, cool and well-ventilated place.
Storage class (TRGS 510)
Storage class 10.

7.3.

Specific end use(s)Specific use(s)The identified uses for this product are detailed in Section 1.2.

SECTION 8: Exposure controls/personal protection
8.1.

Control parameters
Exposure Limits
Chemical name
Dimethyl sulfoxide
67-68-5

European Union-

Austria
TWA: 50 ppm
TWA: 160 mg/m3
H*
Czech Republic-

Chemical name
Dimethyl sulfoxide
67-68-5

Cyprus-Chemical name
Dimethyl sulfoxide
67-68-5

France-Germany TRGS
TWA: 50 ppm
TWA: 160 mg/m3
H*

Chemical name
Dimethyl sulfoxide
67-68-5

Ireland-

Italy MDLPS-SDS – LymphoTrack Assays - MiSeq (CLP)-EN Rev. A | November 2023

Belgium-

Bulgaria-

Croatia-

Denmark
TWA: 50 ppm
TWA: 160 mg/m3
STEL: 100 ppm
STEL: 320 mg/m3

Estonia
TWA: 50 ppm
TWA: 150 mg/m3
STEL: 150 ppm
STEL: 500 mg/m3
A*
Greece-Finland
TWA: 50 ppm
iho*

Latvia-Lithuania
O*
TWA: 50 ppm
TWA: 150 mg/m3
STEL: 150 ppm
STEL: 500 mg/m3

Germany DFG
TWA: 50 ppm
TWA: 160 mg/m3
Peak: 100 ppm
Peak: 320 mg/m3*
Italy AIDII-

Hungary-

17 / 24

LymphoTrack® Assays - MiSeqTM

SECTION 8: Exposure controls/personal protection
Chemical name
Dimethyl sulfoxide
67-68-5

Portugal-

Romania-

Chemical name
Dimethyl sulfoxide
67-68-5

SwedenNGV: 50 ppm
NGV: 150 mg/m3
Vägledande KGV: 150 ppm
Vägledande KGV: 500 mg/m3
H*

Slovakia-

Switzerland
TWA: 50 ppm
TWA: 160 mg/m3
STEL: 100 ppm
STEL: 320 mg/m3
H*

Slovenia
Spain
TWA: 160 mg/m3
TWA: 50 ppm
STEL: 100 ppm
STEL: 320 mg/m3
K*
United Kingdom-

Biological occupational exposure limits
This product, as supplied, does not contain any hazardous materials with biological limits established by the region specific regulatory
bodies.
Derived No Effect Level (DNEL) - Workers
Chemical name
Dimethyl sulfoxide
67-68-5
Notes
[4]
[5]
[6]
[7]
Derived No Effect Level (DNEL) - General Public
Chemical name
Dimethyl sulfoxide
67-68-5
Notes
[4]
[5]
[6]
[7]
Predicted No Effect Concentration (PNEC)
Chemical nameFreshwater

Dimethyl sulfoxide
67-68-5
Chemical name
Dimethyl sulfoxide
67-68-5
8.2.

17 mg/L
Freshwater
sediment
13.4 mg/kg
sediment dw

Exposure controls
Engineering controls

Oral-

Dermal200 mg/kg bw/day [4] [6]Inhalation
484 mg/m3 [4] [6]265 mg/m3 [5] [6]

Systemic health effects.
Local health effects.
Long term.
Short term.

Oral
60 mg/kg
bw/day [4] [6]Dermal-Inhalation
120 mg/m3 [4] [6]47 mg/m3 [5] [6]

Systemic health effects.
Local health effects.
Long term.
Short term.

Freshwater(intermittent
release)-Marine waterAir

1.7 mg/L

Marine water(intermittent
release)-Marine sediment

Sewage treatment

Soil

Food chain-

11 mg/L

3.02 mg/kg soil dw

0.7 g/kg food-Showers
Eyewash stations
Ventilation systems.

Personal protective equipment
Eye/face protection

Wear safety glasses with side shields (or goggles). Eye protection must conform to

SDS – LymphoTrack Assays - MiSeq (CLP)-EN Rev. A | November 2023

18 / 24

LymphoTrack® Assays - MiSeqTM

SECTION 8: Exposure controls/personal protection
standard EN 166.
Wear suitable gloves. Gloves must conform to standard EN 374.
Wear suitable protective clothing (EN ISO 6529).
No protective equipment is needed under normal use conditions. If exposure limits
are exceeded or irritation is experienced, ventilation and evacuation may berequired.
Handle in accordance with good industrial hygiene and safety practice.
No information available.

Hand protection
Skin and body protection
Respiratory protection

General hygiene considerations
Environmental exposure controls

SECTION 9: Physical and chemical properties
9.1.

Information on basic physical and chemical properties
Appearance
Clear liquid
Physical state
LiquidColor
Colorless. Light blue, light yellow, light pink. or light orange
Odor
Odorless
Odor thresholdNo information available
Property
Melting point / freezing point

ValuesRemarks • Method
No data available

Initial boiling point and boiling range

No data available

Flammability

No data available

Flammability Limit in Air
Upper flammability or explosive
limitsLower flammability or explosive
limitsFlash point

No data available

Autoignition temperature

No data available

No data available
No data available

Decomposition temperaturepH
pH (as aqueous solution)

No data available
7

-

9.5

Kinematic viscosity

No data available

Dynamic viscosity

No data available

Water solubility
Solubility(ies)

No data available
No data available

Partition coefficient

No data available

Vapor pressure

No data available

Relative density

No data available

Bulk density

No data available

Liquid Density

No data available

Relative vapor density

No data available

Particle characteristics
Particle Size

No data available

Particle Size Distribution
9.2.

No data available
No data available

No data available

Other information
9.2.1.
9.2.2.

Information with regard to physical hazard classes
Not applicable
Other safety characteristics

SDS – LymphoTrack Assays - MiSeq (CLP)-EN Rev. A | November 2023

19 / 24

LymphoTrack® Assays - MiSeqTM

SECTION 9: Physical and chemical properties
No information available

SECTION 10: Stability and reactivity
10.1. Reactivity
Reactivity

None under normal use conditions.

10.2. Chemical stability
Stability
Explosion data

Stable under normal conditions.

Sensitivity to mechanical impact

None.

Sensitivity to static discharge

None.

10.3. Possibility of hazardous reactions
Possibility of hazardous reactions

None under normal processing.

10.4. Conditions to avoid
Conditions to avoid

None known based on information supplied.

10.5. Incompatible materials
Incompatible materials

None known based on information supplied.

10.6. Hazardous decomposition products
Hazardous decomposition products

None known based on information supplied.

SECTION 11: Toxicological information
11.1. Information on hazard classes as defined in Regulation (EC) No 1272/2008
Information on likely routes of exposure
Product Information
Inhalation

Specific test data for the substance or mixture is not available.

Eye contact

Specific test data for the substance or mixture is not available. Contact with eyes may cause irritation.

Skin contact

Specific test data for the substance or mixture is not available.

Ingestion

Specific test data for the substance or mixture is not available.

Symptoms related to the physical, chemical and toxicological characteristics
Symptoms
None known.
Acute toxicity
Numerical measures of toxicity
Based on available data, the classification criteria are not met.
Component Information
Chemical name
Dimethyl sulfoxide

Oral LD50= 28300 mg/kg( Rat )

Dermal LD50
= 40000 mg/kg ( Rat )Inhalation LC50
> 5.33 mg/L ( Rat ) 4 h

Delayed and immediate effects as well as chronic effects from short and long-term exposure
Skin corrosion/irritation
Based on available data, the classification criteria are not met.
Serious eye damage/eye irritation
Based on available data, the classification criteria are not met.
Respiratory or skin sensitization
Based on available data, the classification criteria are not met.
Germ cell mutagenicity
Based on available data, the classification criteria are not met.
SDS – LymphoTrack Assays - MiSeq (CLP)-EN Rev. A | November 2023

20 / 24

LymphoTrack® Assays - MiSeqTM

SECTION 11: Toxicological information
Carcinogenicity
Reproductive toxicity
STOT - single exposure
STOT - repeated exposure
Aspiration hazard

Based on available data, the classification criteria are not met.
Based on available data, the classification criteria are not met.
Based on available data, the classification criteria are not met.
Based on available data, the classification criteria are not met.
Based on available data, the classification criteria are not met.

11.2. Information on other hazards
11.2.1.
Endocrine disrupting properties
Endocrine disrupting properties
11.2.2.
Other information
Other adverse effects

This product does not contain any known or suspected endocrine disruptors.
No information available.

SECTION 12: Ecological information
12.1. Toxicity
Ecotoxicity

Based on available data, the classification criteria are not met. Based on available data, theclassification criteria are not met.
Unknown aquatic toxicity
Contains 0 % of components with unknown hazards to the aquatic environment.
Chemical name
Algae/aquatic
Fish
Toxicity to
Crustacea
plantsmicroorganisms
Dimethyl sulfoxide
LC50: =34000mg/L (96h, Pimephales promelas)
67-68-5
LC50: 33 - 37g/L (96h, Oncorhynchus mykiss)
LC50: >40g/L (96h, Lepomis macrochirus)
LC50: =41.7g/L (96h, Cyprinus carpio)

12.2. Persistence and degradability
Persistence and degradability

No information available.

12.3. Bioaccumulative potential
Bioaccumulation
Component Information
Chemical name
Dimethyl sulfoxide
12.4. Mobility in soil
Mobility in soil

Partition coefficient-1.35

No information available.

12.5. Results of PBT and vPvB assessment
PBT and vPvB assessment
The product does not contain any substance(s) classified as PBT or vPvB.
Chemical name
PBT and vPvB assessment
Dimethyl sulfoxide
The substance is not PBT / vPvB
67-68-5
12.6. Endocrine disrupting properties
Endocrine disrupting properties

This product does not contain any known or suspected endocrine disruptors.

12.7. Other adverse effects
Other adverse effects

No information available.

SECTION 13: Disposal considerations
13.1. Waste treatment methods
Waste from residues/unused products

Dispose of in accordance with local regulations. Dispose of waste in accordance withenvironmental legislation.

SDS – LymphoTrack Assays - MiSeq (CLP)-EN Rev. A | November 2023

21 / 24

LymphoTrack® Assays - MiSeqTM

SECTION 13: Disposal considerations
Contaminated packaging
Waste codes / waste designations
according to EWC / AVV

Do not reuse empty containers.
According to the European Waste Catalog, Waste Codes are not product specific, but
application specific. Waste codes should be assigned by the user based on theapplication for which the product was used.

SECTION 14: Transport information
IMDG
14.1
14.2
14.3
14.4
14.5
14.6
14.7

Not regulated
Not regulated
Not regulated
Not regulated
Not applicableNot applicable

UN number or ID number
UN proper shipping name
Transport hazard class(es)Packing group
Environmental hazards
Special Precautions for Users
Special Provisions

None

Maritime transport in bulk according
to IMO instruments

RID

Not regulated
Not regulated
Not regulated
Not regulated
Not applicableNot applicable

14.1 UN number
14.2 UN proper shipping name14.3 Transport hazard class(es)14.4 Packing group
14.5 Environmental hazards
14.6 Special Precautions for Users
Special Provisions

None

ADR
14.1
14.2
14.3
14.4
14.5
14.6

IATA
14.1
14.2
14.3
14.4
14.5
14.6
Note:

No information available

Not regulated
Not regulated
Not regulated
Not regulated
Not applicableNot applicable

UN number or ID number
UN proper shipping name
Transport hazard class(es)Packing group
Environmental hazards
Special Precautions for Users
Special Provisions

None
Not regulated
Not regulated
Not regulated
Not regulated
Not applicableNot applicable

UN number or ID number
UN proper shipping name
Transport hazard class(es)Packing group
Environmental hazards
Special Precautions for Users
Special Provisions

None
None

SECTION 15: Regulatory information
15.1. Safety, health and environmental regulations/legislation specific for the substance or mixture
National regulations
FranceOccupational Illnesses (R-463-3, France)

SDS – LymphoTrack Assays - MiSeq (CLP)-EN Rev. A | November 2023

22 / 24

LymphoTrack® Assays - MiSeqTM

SECTION 15: Regulatory information
Chemical name
Dimethyl sulfoxide
67-68-5
Germany
Water hazard class (WGK)

French RG number
RG 84

non-hazardous to water (nwg)

European Union
Take note of Directive 98/24/EC on the protection of the health and safety of workers from the risks related to chemical agents at
work.
Authorizations and/or restrictions on use:
This product contains one or more substance(s) subject to restriction (Regulation (EC) No. 1907/2006 (REACH), Annex XVII)
Chemical nameRestricted substance per REACH Annex
Substance subject to authorization per
XVII
REACH Annex XIV
Dimethyl sulfoxide - 67-68-5
75.
Persistent Organic Pollutants
Not applicable
Ozone-depleting substances (ODS) regulation (EC) 1005/2009
Not applicable
International Inventories
Contact supplier for inventory compliance status
15.2. Chemical safety assessment
Chemical Safety Report

No information available

SECTION 16: Other information
Key or legend to abbreviations and acronyms used in the safety data sheet
Legend
ATE: Acute Toxicity Estimate
SVHC: Substances of Very High Concern for Authorization:
PBT: Persistent, Bioaccumulative, and Toxic (PBT) Substances
vPvB: Very Persistent and very Bioaccumulative (vPvB) Substances
Legend Section 8: Exposure controls/personal protection
TWA
TWA (time-weighted average)
Ceiling
SCBA

Maximum limit value
Self-contained breathing apparatus

Classification procedure
Classification according to Regulation (EC) No. 1272/2008 [CLP]
Acute oral toxicity
Acute dermal toxicity
Acute inhalation toxicity - gas
Acute inhalation toxicity - vapor
Acute inhalation toxicity - dust/mist
Skin corrosion/irritation
Serious eye damage/eye irritation
SDS – LymphoTrack Assays - MiSeq (CLP)-EN Rev. A | November 2023

STEL*

STEL (Short Term Exposure
Limit)
Skin designation

Method Used
Calculation method
Calculation method
Calculation method
Calculation method
Calculation method
Calculation method
Calculation method
23 / 24

LymphoTrack® Assays - MiSeqTM

SECTION 16: Other information
Respiratory sensitization
Skin sensitization
Mutagenicity
Carcinogenicity
Reproductive toxicity
STOT - single exposure
STOT - repeated exposure
Acute aquatic toxicity
Chronic aquatic toxicity
Aspiration hazard
Ozone

Calculation method
Calculation method
Calculation method
On basis of test data
Calculation method
Calculation method
Calculation method
Calculation method
Calculation method
Calculation method
Calculation method

Key literature references and sources for data used to compile the SDS
Agency for Toxic Substances and Disease Registry (ATSDR)
U.S. Environmental Protection Agency ChemView Database
European Food Safety Authority (EFSA)
European Chemicals Agency (ECHA) Committee for Risk Assessment (ECHA_RAC)
European Chemicals Agency (ECHA) (ECHA_API)
EPA (Environmental Protection Agency)
Acute Exposure Guideline Level(s) (AEGL(s))
U.S. Environmental Protection Agency Federal Insecticide, Fungicide, and Rodenticide Act
U.S. Environmental Protection Agency High Production Volume Chemicals
Food Research Journal
Hazardous Substance Database
International Uniform Chemical Information Database (IUCLID)
Japan GHS Classification
Australia National Industrial Chemicals Notification and Assessment Scheme (NICNAS)
NIOSH (National Institute for Occupational Safety and Health)National Library of Medicine's ChemID Plus (NLM CIP)
National Library of Medicine’s PubMed database (NLM PUBMED)
United States of America National Toxicology Program (NTP)New Zealand's Chemical Classification and Information Database (CCID)
Organization for Economic Co-operation and Development Environment, Health, and Safety Publications
Organization for Economic Co-operation and Development High Production Volume Chemicals Program
Organization for Economic Co-operation and Development Screening Information Data Set
World Health Organization
Issuing Date
Revision Date
Revision Note

27-Apr-2023
27-Apr-2023
Initial Release.

This safety data sheet complies with the requirements of Commission Regulation (EU) 2020/878 of 18 June 2020 amending Regulation (EC)No. 1907/2006
Disclaimer
The information provided in this Safety Data Sheet is correct to the best of our knowledge, information and belief at the date of its
publication. The information given is designed only as a guidance for safe handling, use, processing, storage, transportation, disposal andrelease and is not to be considered a warranty or quality specification. The information relates only to the specific material designated andmay not be valid for such material used in combination with any other materials or in any process, unless specified in the text.
End of Safety Data SheetSDS – LymphoTrack Assays - MiSeq (CLP)-EN Rev. A | November 2023

24 / 24